These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

118 related articles for article (PubMed ID: 16914572)

  • 1. Progenitor marker CD133 mRNA is elevated in peripheral blood of cancer patients with bone metastases.
    Mehra N; Penning M; Maas J; Beerepoot LV; van Daal N; van Gils CH; Giles RH; Voest EE
    Clin Cancer Res; 2006 Aug; 12(16):4859-66. PubMed ID: 16914572
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Elevated circulating endothelial progenitor marker CD133 messenger RNA levels predict colon cancer recurrence.
    Lin EH; Hassan M; Li Y; Zhao H; Nooka A; Sorenson E; Xie K; Champlin R; Wu X; Li D
    Cancer; 2007 Aug; 110(3):534-42. PubMed ID: 17594720
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Tumour CD133 mRNA expression and clinical outcome in surgically resected colorectal cancer patients.
    Artells R; Moreno I; Díaz T; Martínez F; Gel B; Navarro A; Ibeas R; Moreno J; Monzó M
    Eur J Cancer; 2010 Feb; 46(3):642-9. PubMed ID: 20005089
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Colon cancer stem cell markers CD44 and CD133 in patients with colorectal cancer and synchronous hepatic metastases.
    Jing F; Kim HJ; Kim CH; Kim YJ; Lee JH; Kim HR
    Int J Oncol; 2015 Apr; 46(4):1582-8. PubMed ID: 25625240
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Prognostic impact of CD133 mRNA expression in 48 glioblastoma patients treated with concomitant radiochemotherapy: a prospective patient cohort at a single institution.
    Metellus P; Nanni-Metellus I; Delfino C; Colin C; Tchogandjian A; Coulibaly B; Fina F; Loundou A; Barrie M; Chinot O; Ouafik L; Figarella-Branger D
    Ann Surg Oncol; 2011 Oct; 18(10):2937-45. PubMed ID: 21479688
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Quantification of peripheral blood CD133 mRNA in identifying metastasis and in predicting recurrence of patients with clear cell renal cell carcinoma.
    Feng G; Jiang F; Pan C; Pu C; Huang H; Li G
    Urol Oncol; 2014 Jan; 32(1):44.e9-14. PubMed ID: 24054866
    [TBL] [Abstract][Full Text] [Related]  

  • 7. High expression of octamer-binding transcription factor 4A, prominin-1 and aldehyde dehydrogenase strongly indicates involvement in the initiation of lung adenocarcinoma resulting in shorter disease-free intervals.
    Cortes-Dericks L; Galetta D; Spaggiari L; Schmid RA; Karoubi G
    Eur J Cardiothorac Surg; 2012 Jun; 41(6):e173-81. PubMed ID: 22529186
    [TBL] [Abstract][Full Text] [Related]  

  • 8. CD133 mRNA expression and microsatellite instability in colorectal carcinoma.
    Huh JW; Park YS; Lee JH; Kim HR; Shin MG; Kim YJ
    J Surg Oncol; 2010 Dec; 102(7):765-70. PubMed ID: 20872808
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Identification and clinical significance of circulating endothelial progenitor cells in human non-small cell lung cancer.
    Dome B; Timar J; Dobos J; Meszaros L; Raso E; Paku S; Kenessey I; Ostoros G; Magyar M; Ladanyi A; Bogos K; Tovari J
    Cancer Res; 2006 Jul; 66(14):7341-7. PubMed ID: 16849585
    [TBL] [Abstract][Full Text] [Related]  

  • 10. The relationship of CD133, histone deacetylase 1 and thrombospondin-1 in gastric cancer.
    Eto S; Yoshikawa K; Shimada M; Higashijima J; Tokunaga T; Nakao T; Nishi M; Takasu C; Sato H; Kurita N
    Anticancer Res; 2015 Apr; 35(4):2071-6. PubMed ID: 25862862
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Pharmacogenetic profiling of CD133 is associated with response rate (RR) and progression-free survival (PFS) in patients with metastatic colorectal cancer (mCRC), treated with bevacizumab-based chemotherapy.
    Pohl A; El-Khoueiry A; Yang D; Zhang W; Lurje G; Ning Y; Winder T; Hu-Lieskoven S; Iqbal S; Danenberg KD; Kahn M; Teo JL; Shriki J; Stebbing J; Lenz HJ
    Pharmacogenomics J; 2013 Apr; 13(2):173-80. PubMed ID: 22231565
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Elevated CD133, but not VEGF or EGFR, as a predictive marker of distant recurrence after preoperative chemoradiotherapy in rectal cancer.
    Yasuda H; Tanaka K; Saigusa S; Toiyama Y; Koike Y; Okugawa Y; Yokoe T; Kawamoto A; Inoue Y; Miki C; Kusunoki M
    Oncol Rep; 2009 Oct; 22(4):709-17. PubMed ID: 19724847
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Granulocyte colony-stimulating factor mobilizes functional endothelial progenitor cells in patients with coronary artery disease.
    Powell TM; Paul JD; Hill JM; Thompson M; Benjamin M; Rodrigo M; McCoy JP; Read EJ; Khuu HM; Leitman SF; Finkel T; Cannon RO
    Arterioscler Thromb Vasc Biol; 2005 Feb; 25(2):296-301. PubMed ID: 15569821
    [TBL] [Abstract][Full Text] [Related]  

  • 14. mTOR signal and hypoxia-inducible factor-1 alpha regulate CD133 expression in cancer cells.
    Matsumoto K; Arao T; Tanaka K; Kaneda H; Kudo K; Fujita Y; Tamura D; Aomatsu K; Tamura T; Yamada Y; Saijo N; Nishio K
    Cancer Res; 2009 Sep; 69(18):7160-4. PubMed ID: 19738050
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Prognostic value of circulating CD133(+) cells in patients with gastric cancer.
    Xia P; Song CL; Liu JF; Wang D; Xu XY
    Cell Prolif; 2015 Jun; 48(3):311-7. PubMed ID: 25727099
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Peripheral blood mononuclear CD133 mRNA levels correlates with response to treatment in patients with gastrointestinal stromal tumors.
    Deng Y; Hassan MM; Mo J; Lin EH
    PLoS One; 2013; 8(2):e55520. PubMed ID: 23408993
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Overexpression of B7-H3 in CD133+ colorectal cancer cells is associated with cancer progression and survival in human patients.
    Bin Z; Guangbo Z; Yan G; Huan Z; Desheng L; Xueguang Z
    J Surg Res; 2014 May; 188(2):396-403. PubMed ID: 24630518
    [TBL] [Abstract][Full Text] [Related]  

  • 18. The AC133 epitope, but not the CD133 protein, is lost upon cancer stem cell differentiation.
    Kemper K; Sprick MR; de Bree M; Scopelliti A; Vermeulen L; Hoek M; Zeilstra J; Pals ST; Mehmet H; Stassi G; Medema JP
    Cancer Res; 2010 Jan; 70(2):719-29. PubMed ID: 20068153
    [TBL] [Abstract][Full Text] [Related]  

  • 19. CD133 marks a stem cell population that drives human primary myelofibrosis.
    Triviai I; Stübig T; Niebuhr B; Hussein K; Tsiftsoglou A; Fehse B; Stocking C; Kröger N
    Haematologica; 2015 Jun; 100(6):768-79. PubMed ID: 25724578
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Is CD133 mRNA expression a prognostic factor in colorectal cancer?
    Hayama T; Watanabe T; Iinuma H
    J Surg Oncol; 2011 Jul; 104(1):110. PubMed ID: 21360712
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 6.